Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03568890 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Study acronym: ANDES
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: details revised at 16 of 17 entriesv10
  2. Trial status: Recruiting to Active, Not Recruitingv9 Show 4 more changesShow less
    • Primary completion date changed from estimate of Dec 1, 2025 to Aug 1, 2025
    • Study completion date: Sep 1, 2026 to Sep 1, 2030
    • Site details revised
    • Publications: details revised at 16 of 17 entries
  3. Primary completion date: Dec 1, 2023 to Dec 1, 2025v8 Show 5 more changesShow less
    • Primary endpoints: 1 to 2
    • Enrollment target: 350 to 510
    • Eligibility criteria expanded, about 30 words
    • Secondary endpoints: 3 to 5
    • Study description expanded, about 68 words
  4. Primary completion date: Sep 1, 2023 to Dec 1, 2023v7
  5. Primary completion date: Sep 1, 2022 to Sep 1, 2023
    • Study completion date: Sep 1, 2025 to Sep 1, 2026
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Sep 1, 2020 to Sep 1, 2022v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v3
  4. Study description expanded, about 78 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to compare short-term (8 weeks) anticoagulation therapy (DOAC) vs. antiplatelet therapy for the prevention of device thrombosis following transcatheter LAAC.
Trial Details
NCT Number NCT03568890
Lead Sponsor Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Conditions
(from sponsor)		 Left Atrial Appendage Closure, Thrombosis, Stroke, TIA, Bleeding
Related terms Hemorrhage, Stroke, Thrombosis
Enrollment 510 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov